CN101166541A - 用于修复心脏组织的方法和组合物 - Google Patents

用于修复心脏组织的方法和组合物 Download PDF

Info

Publication number
CN101166541A
CN101166541A CNA2006800143013A CN200680014301A CN101166541A CN 101166541 A CN101166541 A CN 101166541A CN A2006800143013 A CNA2006800143013 A CN A2006800143013A CN 200680014301 A CN200680014301 A CN 200680014301A CN 101166541 A CN101166541 A CN 101166541A
Authority
CN
China
Prior art keywords
blood
cell
stem cell
tvemf
amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800143013A
Other languages
English (en)
Chinese (zh)
Inventor
唐尼·拉德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenetech Inc
Original Assignee
Regenetech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenetech Inc filed Critical Regenetech Inc
Publication of CN101166541A publication Critical patent/CN101166541A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800143013A 2005-02-28 2006-02-27 用于修复心脏组织的方法和组合物 Pending CN101166541A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65728705P 2005-02-28 2005-02-28
US60/657,287 2005-02-28

Publications (1)

Publication Number Publication Date
CN101166541A true CN101166541A (zh) 2008-04-23

Family

ID=36941686

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800143013A Pending CN101166541A (zh) 2005-02-28 2006-02-27 用于修复心脏组织的方法和组合物

Country Status (11)

Country Link
US (1) US20060193836A1 (cg-RX-API-DMAC7.html)
EP (1) EP1853301A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008531696A (cg-RX-API-DMAC7.html)
KR (1) KR20070112205A (cg-RX-API-DMAC7.html)
CN (1) CN101166541A (cg-RX-API-DMAC7.html)
BR (1) BRPI0608277A2 (cg-RX-API-DMAC7.html)
CA (1) CA2599332A1 (cg-RX-API-DMAC7.html)
EA (1) EA200701599A1 (cg-RX-API-DMAC7.html)
IL (1) IL185557A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010451A (cg-RX-API-DMAC7.html)
WO (1) WO2006093860A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111313782A (zh) * 2020-01-20 2020-06-19 江苏新安电器股份有限公司 基于免疫算法的感应电机无源性控制系统及其控制方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
MY147516A (en) 2005-11-07 2012-12-31 Amorcyte Inc Compositions and method of vascular injury repair cross-reference to related applications
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
JP5705127B2 (ja) * 2008-12-03 2015-04-22 アモーサイト インコーポレイテッド 梗塞領域灌流改善組成物および血管損傷修復の方法
SG11201603166UA (en) 2013-10-24 2016-05-30 Ospedale San Raffaele Srl Method
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5153132A (en) * 1988-06-30 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional co-culture process
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
US4988623A (en) * 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US20020159984A1 (en) * 1999-11-12 2002-10-31 Quality Biological, Inc. Cultivation of cells for long term engraftment
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
US20040076620A1 (en) * 2002-09-03 2004-04-22 Donnie Rudd Method of repairing primate mammalian tissue
US20060051860A1 (en) * 2002-11-15 2006-03-09 Kyushu Tlo Company, Limited Method of organ regeneration
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111313782A (zh) * 2020-01-20 2020-06-19 江苏新安电器股份有限公司 基于免疫算法的感应电机无源性控制系统及其控制方法
CN111313782B (zh) * 2020-01-20 2022-03-01 江苏新安电器股份有限公司 基于免疫算法的感应电机无源性控制方法

Also Published As

Publication number Publication date
EP1853301A2 (en) 2007-11-14
BRPI0608277A2 (pt) 2009-11-24
MX2007010451A (es) 2007-11-08
CA2599332A1 (en) 2006-09-08
KR20070112205A (ko) 2007-11-22
US20060193836A1 (en) 2006-08-31
EA200701599A1 (ru) 2008-04-28
WO2006093860A3 (en) 2007-04-12
WO2006093860A2 (en) 2006-09-08
IL185557A0 (en) 2008-01-06
JP2008531696A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
TW201130977A (en) Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood
US20070117087A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a compositoin thereof
US20080050348A1 (en) Method and composition for repairing heart tissue
US20060188984A1 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
RU2312141C2 (ru) Среда для культивирования аутологических человеческих стволовых клеток-предшественников и способы их применения
KR20080042761A (ko) 렙틴을 이용한 줄기세포 증식방법
CN101166541A (zh) 用于修复心脏组织的方法和组合物
RU2647429C1 (ru) Биомедицинский клеточный препарат
WO2009025722A1 (en) Method and composition for repairing heart tissue
US20060193838A1 (en) Method and composition for treating diabetes
CN110882276B (zh) 细胞治疗组合物及治疗血管病变的方法
WO2013168402A1 (ja) デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液
Bērziņš et al. Characterisation and in vivo safety of canine adipose-derived stem cells
KR100569609B1 (ko) 세포면역치료제의 제조를 위한 림프구 장기 보관 방법
US20220218759A1 (en) Compositions and methods for improving treatment outcomes for patients having hematological malignancies using an expanded stem cell product
CA2597954A1 (en) Method and composition for repairing heart tissue
CA2597963A1 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2007058929A2 (en) Composition for reducing problems associated with sickle cell disease using low temperature storage
Von Hoff et al. Cloning of primary human tumor colony forming units in glass capillaries
Hongbao et al. Brookdale Hospital, Brooklyn, New York 11212, USA; 2 Cambridge, MA 02138, USA ma8080@ gmail. com

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080423